These recommended abstracts from ESMO 2022 Annual meeting have been selected by Robert A. Figlin, MD, Editor-in-
Chief of the Kidney Cancer Journal. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reﬂect
the foremost research and strategies from latest clinical trials that
impact the current standard of care in renal cancer.